Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 555,509
  • Shares Outstanding, K 301,907
  • Annual Sales, $ 154,010 K
  • Annual Income, $ -309,850 K
  • EBIT $ -191 M
  • EBITDA $ 34 M
  • 60-Month Beta 2.27
  • Price/Sales 3.66
  • Price/Cash Flow N/A
  • Price/Book 15.31

Options Overview Details

View History
  • Implied Volatility 139.43% (+23.96%)
  • Historical Volatility 88.97%
  • IV Percentile 84%
  • IV Rank 17.04%
  • IV High 412.87% on 04/16/25
  • IV Low 83.27% on 08/25/25
  • Expected Move (DTE 8) 0.2975 (16.17%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 743
  • Volume Avg (30-Day) 1,765
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 69,431
  • Open Int (30-Day) 78,889
  • Expected Range 1.5425 to 2.1375

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6800 +9.52%
on 02/05/26
2.7300 -32.60%
on 01/23/26
-0.1000 (-5.15%)
since 01/09/26
3-Month
1.5235 +20.77%
on 11/18/25
2.7300 -32.60%
on 01/23/26
-0.0200 (-1.08%)
since 11/11/25
52-Week
0.8500 +116.47%
on 05/28/25
2.7300 -32.60%
on 01/23/26
+0.5100 (+38.35%)
since 02/11/25

Most Recent Stories

More News
PacBio Earnings: What To Look For From PACB

PacBio Earnings: What To Look For From PACB

PACB : 1.8400 (+1.66%)
3 Cash-Burning Stocks We Approach with Caution

3 Cash-Burning Stocks We Approach with Caution

LOVE : 13.04 (-2.25%)
JELD : 2.78 (-2.46%)
PACB : 1.8400 (+1.66%)
PacBio Completes Sale of Short-Read Sequencing Assets

MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select...

PACB : 1.8400 (+1.66%)
3 Stocks Under $10 with Warning Signs

3 Stocks Under $10 with Warning Signs

PACB : 1.8400 (+1.66%)
BLNK : 0.6852 (-0.19%)
WU : 9.90 (-2.08%)
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial...

PACB : 1.8400 (+1.66%)
3 Unpopular Stocks That Concern Us

3 Unpopular Stocks That Concern Us

PACB : 1.8400 (+1.66%)
HD : 390.68 (+0.26%)
M : 21.73 (+3.53%)
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration...

PACB : 1.8400 (+1.66%)
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the...

PACB : 1.8400 (+1.66%)
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s...

PACB : 1.8400 (+1.66%)
3 Reasons to Sell PACB and 1 Stock to Buy Instead

3 Reasons to Sell PACB and 1 Stock to Buy Instead

PACB : 1.8400 (+1.66%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 2.0083
2nd Resistance Point 1.9267
1st Resistance Point 1.8833
Last Price 1.8400
1st Support Level 1.7583
2nd Support Level 1.6767
3rd Support Level 1.6333

See More

52-Week High 2.7300
Fibonacci 61.8% 2.0118
Last Price 1.8400
Fibonacci 50% 1.7900
Fibonacci 38.2% 1.5682
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar